Shoubing Zhou

596 total citations
13 papers, 149 citations indexed

About

Shoubing Zhou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shoubing Zhou has authored 13 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shoubing Zhou's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Cells and Metastasis (2 papers). Shoubing Zhou is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Cells and Metastasis (2 papers). Shoubing Zhou collaborates with scholars based in China, United States and South Korea. Shoubing Zhou's co-authors include Xiu Zhang, Shiya Zheng, Cailian Wang, Xiaoxiao Jin, Yan-wen Liu, Dan Wu, Xiao‐Dong Yin, Zhigang Zhang, Xiyong Wang and Lei Zhang and has published in prestigious journals such as Advanced Science, RSC Advances and Journal of Thoracic Oncology.

In The Last Decade

Shoubing Zhou

12 papers receiving 147 citations

Peers

Shoubing Zhou

BIOMA

ONCOL

PRM

Natalie K. Horvat United States

Kong Fan-min China

Donglei Zhu China

Zhenhu He China

Caifang Ni China

Jolanta Jedrzkiewicz United States

Caroline Denis France

Eunjue Yi South Korea

Xianping Lv China

Zhenzhai Cai China

Natalie K. Horvat United States

Shoubing Zhou

46 ×0.8

32 ×0.7

BIOMA

28 ×0.7

20 ×0.6

ONCOL

16 ×0.6

PRM

Citations per year, relative to Shoubing Zhou Shoubing Zhou (= 1×) peers Natalie K. Horvat

Countries citing papers authored by Shoubing Zhou

Since Specialization

Citations

This map shows the geographic impact of Shoubing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoubing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoubing Zhou more than expected).

Fields of papers citing papers by Shoubing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoubing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoubing Zhou. The network helps show where Shoubing Zhou may publish in the future.

Co-authorship network of co-authors of Shoubing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shoubing Zhou. A scholar is included among the top collaborators of Shoubing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoubing Zhou. Shoubing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Muziying, Dan Zhao, Guilai Liu, et al.. (2025). FcRn-guided antigen trafficking enhances cancer vaccine efficacy. Cancer Immunology Immunotherapy. 74(2). 54–54. 1 indexed citations

Zhou, Shoubing, et al.. (2025). Reprogramming the tumor microenvironment: synergistic mechanisms of antibody–drug conjugates and immune checkpoint inhibitors. PubMed. 8(3). 262–274.

Zhou, Shoubing, et al.. (2025). Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. Frontiers in Cell and Developmental Biology. 13. 1619597–1619597. 2 indexed citations

Zhou, Shoubing, Dan Zhao, Xiaolong Yuan, et al.. (2025). Reprogramming the Tumor Immune Microenvironment with ICAM‐1‐Targeted Antibody‒Drug Conjugates and B7‐H3‐CD3 Bispecific Antibodies. Advanced Science. 12(16). e2415577–e2415577. 2 indexed citations

Zhou, Shoubing, et al.. (2024). Synergistic approach to combating triple-negative breast cancer: DDR1-targeted antibody-drug conjugate combined with pembrolizumab. Journal of Pharmaceutical Analysis. 15(5). 101100–101100. 3 indexed citations

Jin, Wei, Benjie Shan, Hu Liu, et al.. (2020). The correlation between blood lipids and clinicopathological features of breast cancer in young females. Gland Surgery. 9(5). 1443–1449. 1 indexed citations

Jin, Wei, Benjie Shan, Hu Liu, et al.. (2019). Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping. Journal of Thoracic Oncology. 14(7). e137–e139. 23 indexed citations

Zhou, Shoubing, et al.. (2019). Targeted Luteolin Delivery via Bevacizumab-Modified Polymer Microbubbles to Colon Cancer Cells. Nanoscience and Nanotechnology Letters. 11(2). 240–248. 1 indexed citations

Tian, Jilai, Hongming Zhang, Shoubing Zhou, et al.. (2018). Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer. APOPTOSIS. 23(5-6). 356–374. 36 indexed citations

10.

Zhou, Shoubing, Dan Wu, Xiao‐Dong Yin, et al.. (2017). Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells. Journal of Experimental & Clinical Cancer Research. 36(1). 24–24. 65 indexed citations

11.

Zheng, Shiya, Yanping Chen, Dan Wu, et al.. (2016). Simultaneous and combined detection of multiple tumor markers for cancer screening in human serum by an upgraded photonic crystal-encoded suspension array. RSC Advances. 6(95). 92267–92275. 4 indexed citations

12.

Zheng, Shiya, Yanping Chen, Shoubing Zhou, et al.. (2016). Correction: Simultaneous and combined detection of multiple tumor markers for cancer screening in human serum by an upgraded photonic crystal-encoded suspension array. RSC Advances. 6(98). 96202–96202. 1 indexed citations

13.

Zhou, Shoubing, et al.. (2015). Rituximab-conjugated and doxorubicin-loaded microbubbles combined with ultrasound irradiation inhibits proliferation and induces apoptosis in Raji cell lines. Oncology Reports. 35(2). 801–808. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact